{"name": "MiCardia Corporation",
 "permalink": "micardia-corporation",
 "crunchbase_url": "http://www.crunchbase.com/company/micardia-corporation",
 "homepage_url": "http://www.micardia.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@micardia.com",
 "phone_number": "1-949-951-4888",
 "description": "",
 "created_at": "Wed Jul 11 05:37:52 UTC 2012",
 "updated_at": "Fri May 31 12:54:25 UTC 2013",
 "overview": "\u003Cp\u003EMiCardia is a privately held medical device company currently preparing for the commercialization of its first series of products, enCor\u2122, in the European Union. enCor is a unique device that surgically treats mitral valve regurgitation. enCor utilizes the company\u0026#8217;s patented technology, Dynaplasty\u2122, to provide a \u0026#8220;second chance\u0026#8221; to the patient who develops recurrent regurgitation. enCor can be activated to physiologically adjust the mitral valve leaflets to resolve regurgitation, minimally invasively, weeks to years later, without the need for the risk and cost of redo surgery.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0020/0075/200075v1-max-150x150.jpg"],
     [[197,
       80],
      "assets/images/resized/0020/0075/200075v1-max-250x250.jpg"],
     [[197,
       80],
      "assets/images/resized/0020/0075/200075v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.7M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1309313/000130931313000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 3696105.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 4,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "30 Hughes, Suite 206",
    "address2": "",
    "zip_code": "92618",
    "city": "Irvine",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "MiCardia Corporation Completes Financing and Spin-off of its Transcatheter Technology to a New Cardiovascular Company, ValCare, Inc.",
    "stoned_year": 2012,
    "stoned_month": 7,
    "stoned_day": 10,
    "source_url": "http://finance.yahoo.com/news/micardia-corporation-completes-financing-spin-184800893.html",
    "source_text": " ",
    "source_description": "MiCardia Corporation Completes Financing and Spin-off of its Transcatheter Technology to a New Cardiovascular Company, ValCare, Inc.",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "MiCardia Corporation",
      "permalink": "micardia-corporation"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        126],
       "assets/images/resized/0020/0076/200076v1-max-150x150.jpg"],
      [[250,
        210],
       "assets/images/resized/0020/0076/200076v1-max-250x250.jpg"],
      [[450,
        379],
       "assets/images/resized/0020/0076/200076v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}